Neoplasms

Showing NaN - NaN of 63

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tumors, Esophageal Tumors, Esophagus Tumor Trial run by the National Cancer Institute (NCI) (Nivolumab, Entinostat, Montanide(R)

Not yet recruiting
  • Neoplasms
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 16, 2023

Respiratory Tract Diseases, Tumors, Tumors by Histologic Type Trial run by the National Cancer Institute (NCI) (Bevacizumab)

Not yet recruiting
  • Respiratory Tract Diseases
  • +14 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 10, 2023

Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

Recruiting
  • Tumor
  • +20 more
  • Mobile, Alabama
  • +81 more
Jan 24, 2023

Clinical and Genetic Studies of Li-Fraumeni Syndrome

Recruiting
  • Li-Fraumeni Syndrome
  • +2 more
    • Bethesda, Maryland
    • +1 more
    Jan 25, 2023

    Tumors Trial run by the National Cancer Institute (NCI) (FdCyd + THU)

    Completed
    • Neoplasms
    • FdCyd + THU
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 24, 2023

    Collection of Tissue Samples for Cancer Research

    Recruiting
    • Neoplasms
    • +3 more
    • Biopsy
    • Atlanta, Georgia
    • +9 more
    Jan 23, 2023

    Tumors, Solid Tumors Trial run by the National Cancer Institute (NCI) (aza-TdC)

    Recruiting
    • Neoplasms
    • Solid Tumors
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Tissue Specimens From Solid Tumors or Blood Disorders and Their

    Recruiting
    • Neoplasms
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 21, 2023

      Tumors Trial run by the NCI (Nilotinib and Paclitaxel)

      Recruiting
      • Neoplasms
      • Nilotinib and Paclitaxel
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 19, 2023

      NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in United States (furmonertinib 240 mg, furmonertinib 160 mg, platinum-based chemo)

      Recruiting
      • Non-Small Cell Lung Cancer
      • +13 more
      • furmonertinib 240 mg
      • +2 more
      • Yuma, Arizona
      • +37 more
      Dec 14, 2022

      Tracking for the Developmental Therapeutics Clinic

      Recruiting
      • Neoplasms
      • Lymphoma
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Dec 9, 2022

        Data Collection, Clinical Care and Interventions in CCR, NCI

        Enrolling by invitation
        • Neoplasms
        • Cancer
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Aug 20, 2022

          Omics of Cancer: OncoGenomics

          Not yet recruiting
          • Neoplasms
          • Cancer
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Aug 17, 2022

            Tumors, Solid Tumors Trial run by the NCI (TdCyd)

            Suspended
            • Neoplasms
            • Solid Tumors
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Aug 6, 2022

            Tumors Trial in Worldwide (Gene-modified (GM) T cell therapy)

            Recruiting
            • Neoplasms
            • Gene-modified (GM) T cell therapy
            • Birmingham, Alabama
            • +173 more
            Aug 1, 2022

            Mobile Sensor Technologies to Assess General Symptomology of

            Enrolling by invitation
            • Neoplasms
            • +4 more
              • Bethesda, Maryland
                National Institutes of Health Clinical Center
              Jul 20, 2022

              Tumors, Lymphoma Trial run by the National Cancer Institute (NCI) (LMP400, LMP776)

              Completed
              • Neoplasms
              • Lymphoma
              • Bethesda, Maryland
                National Institutes of Health Clinical Center, 9000 Rockville Pi
              Apr 7, 2022

              Tumors, Pancreatic Tumors Trial run by the NCI (LMB-100, Nab-Paclitaxel, Mesothelin Expression)

              Completed
              • Neoplasms
              • Pancreatic Neoplasms
              • Bethesda, Maryland
                National Institutes of Health Clinical Center
              Feb 16, 2022

              Carcinoma, Endometrial Adenocarcinoma, Tumors Trial in United States (PEN-866 Sodium, fluorouracil, Folinic acid)

              Recruiting
              • Carcinoma
              • +18 more
              • PEN-866 Sodium
              • +3 more
              • Springdale, Arkansas
              • +15 more
              Feb 16, 2022

              Tumors Trial in Bethesda, Boston, Houston (Veliparib + VX-970 + Cisplatin)

              Completed
              • Neoplasms
              • Veliparib + VX-970 + Cisplatin
              • Bethesda, Maryland
              • +2 more
              Jan 14, 2022

              Tumors Trial in Worldwide (GSK adoptive cell therapy)

              Recruiting
              • Neoplasms
              • GSK adoptive cell therapy
              • Duarte, California
              • +37 more
              Feb 1, 2022

              Tumors Trial in Canada, United States (JNJ-63898081)

              Completed
              • Neoplasms
              • San Francisco, California
              • +6 more
              Dec 2, 2021

              Tumors Trial in United States (NY-ESO-1(c259)T Cells, Fludarabine, Cyclophosphamide)

              Completed
              • Neoplasms
              • NY-ESO-1(c259)T Cells
              • +2 more
              • Duarte, California
              • +7 more
              Jun 9, 2021

              Sarcoma, Stomach Tumors, Tumors Trial run by the NCI (Pazopanib, ARQ 197)

              Completed
              • Sarcoma
              • +2 more
              • Bethesda, Maryland
                National Institutes of Health Clinical Center, 9000 Rockville Pi
              Jun 23, 2021

              Clinical Sequencing of Cancer and Tissue Repository:

              Withdrawn
              • Neoplasms
              • +3 more
                • Bethesda, Maryland
                  National Institutes of Health Clinical Center
                Oct 7, 2020